Evidence map›Paper›PMID 40178306›Full record

ArticleAntimicrobial agents and chemotherapy2025

Evaluation of phenotypic and genotypic methods for detecting KPC variants.

Yasmine Benhadid-Brahmi, Claire Amaris Hobson, Lydia Abdelmoumene, Ella Jaouen, Mélanie Magnan, Maud Gits-Muselli, Mathilde Lescat, Olivier Tenaillon, Stéphane Bonacorsi, André Birgy

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Emergence and dissemination ofMicrobiology spectrum · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yasmine Benhadid-BrahmiIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.ORCID 0000-0002-8147-873X
Claire Amaris HobsonIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.
Lydia AbdelmoumeneIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.
Ella JaouenIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.
Mélanie MagnanIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.
Maud Gits-MuselliIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.
Mathilde LescatIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.
Olivier TenaillonIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.
Stéphane BonacorsiIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.
André BirgyIAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.ORCID 0000-0001-9462-0582

Funding

Institut National de la Santé et de la Recherche Médicale
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesKlebsiella pneumoniaeGenotypeHumansMicrobial Sensitivity TestsPhenotypeAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemaseclinical KPC variantsdetection testshydrolysis-based testsKPC beta-lactamaseLFIA tests

Identifiers

PMID40178306
PMCPMC12057356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.